South Korea Thrombectomy & Embolectomy Devices Market Insight
Published: 01 July 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The market for thrombectomy and embolectomy devices in South Korea is anticipated to grow at compound annual growth rate of 6.2% as result of increased stroke incidence and adoption of sophisticated devices.
South Korea Thrombectomy & Embolectomy Devices Market Insights Forecasts to 2035
- The South Korea Thrombectomy & Embolectomy Devices Market Size Was Estimated USD 168.4 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.2% from 2025 to 2035
- The South Korea Thrombectomy & Embolectomy Devices Market Size is Expected to rise around USD 307.3 Million by 2035
Notable Insights for the South Korea Thrombectomy & Embolectomy Devices Market
- According to product segmentation, aspiration/suction devices exhibit the quickest growth due to technological improvements and clinical preference for effective clot removal, while clot retrievers lead the market as the largest revenue category.
- According to application segmentation, the market is dominated by neurovascular applications for ischemic stroke, followed by peripheral vascular applications for PE and DVT, with stroke centers increasing access to sophisticated thrombectomy techniques.
- With about 80,000 ischemic stroke cases per year, the government of South Korea supports the industry by growing networks of stroke centers and enhancing reimbursement guidelines for mechanical thrombectomy operations under new DRG systems.
- According to data, operating income from thrombectomy treatments reached USD 137.8 million in 2024E, indicating considerable hospital investment and adoption of cutting-edge clot management technologies.
Download the eBook (ToC)
Why Buy This Report
- It will help you plan and make investment decisions by giving you all the information you need about the South Korea Thrombectomy and Embolectomy Devices Market.
- It will help you understand the South Korea Thrombectomy and Embolectomy Devices Market by dividing it into types of products and applications.
- With thorough competition analysis, businesses can effectively target the most profitable end-use sectors and applications, such as peripheral vascular, neurovascular, and heart disease therapies.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea thrombectomy & embolectomy devices market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Thrombectomy & Embolectomy Devices Market
- Medtronic PLC
- Stryker Corporation
- Penumbra Inc.
- Johnson & Johnson
- Terumo Corporation
- MicroPort Scientific Corporation
- Phenox GmbH
- Acandis GmbH
- Vesalio
- Next Biomedical Co., Ltd.
Recent Developments:
- In February 2025, Medtronic PLC expanded its neurovascular portfolio for stroke intervention by introducing the PipelineTM Vantage with Shield Technology flow diverter in more Asia-Pacific markets, including South Korea.
- In October 2024, expanded clinical education and physician training programs for the EMBOTRAP and CEREGLIDE neurovascular platforms in partnership with top stroke centers in Asia-Pacific.
Market Segmentation:
South Korea Thrombectomy & Embolectomy Devices Market, By Product Type
- Clot Retrievers
- Aspiration/Suction Devices
- Vascular Snares
South Korea Thrombectomy & Embolectomy Devices Market, By Application
- Neurovascular (Ischemic Stroke)
- Peripheral Vascular (DVT & PE)
- Coronary Disease
South Korea Thrombectomy & Embolectomy Devices Market, By End-Use
- Hospitals
- Stroke Centers
- Ambulatory Surgical Centers
Expert Views:
South Korean thrombectomy and embolectomy devices market is expected to witness growth in the coming years on account of high incidence of strokes, developments in neurovascular techniques, and technological innovations. It is a very competitive market and is controlled by some of the largest international companies, who constantly endeavor to innovate. It is anticipated that the market will sustain its growth until 2035.
Author: Govind and Krishna By Decisions Advisors and Consulting